CHARLES LEWIS: Open Payments
NPI 1376540765 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 17 payments from 1 company in 2025. Trend: 2023 $525 · 2024 $309 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $628 |
Products named: INGREZZA.
Industry payments across AR — which companies pay providers there.
